227 related articles for article (PubMed ID: 24094713)
21. Imaging work-up for screening of paraganglioma and pheochromocytoma in SDHx mutation carriers: a multicenter prospective study from the PGL.EVA Investigators.
Gimenez-Roqueplo AP; Caumont-Prim A; Houzard C; Hignette C; Hernigou A; Halimi P; Niccoli P; Leboulleux S; Amar L; Borson-Chazot F; Cardot-Bauters C; Delemer B; Chabolle F; Coupier I; Libé R; Peitzsch M; Peyrard S; Tenenbaum F; Plouin PF; Chatellier G; Rohmer V
J Clin Endocrinol Metab; 2013 Jan; 98(1):E162-73. PubMed ID: 23162105
[TBL] [Abstract][Full Text] [Related]
22. PET/CT comparing (68)Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma.
Janssen I; Chen CC; Millo CM; Ling A; Taieb D; Lin FI; Adams KT; Wolf KI; Herscovitch P; Fojo AT; Buchmann I; Kebebew E; Pacak K
Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1784-91. PubMed ID: 26996779
[TBL] [Abstract][Full Text] [Related]
23. The management of head-and-neck paragangliomas.
Capatina C; Ntali G; Karavitaki N; Grossman AB
Endocr Relat Cancer; 2013 Oct; 20(5):R291-305. PubMed ID: 23921204
[TBL] [Abstract][Full Text] [Related]
24.
Kroiss AS; Uprimny C; Shulkin BL; Gruber L; Frech A; Url C; Riechelmann H; Sprinzl GM; Thomé C; Treglia G; Kjaer A; Fraedrich G; Virgolini IJ
Nucl Med Biol; 2019 Apr; 71():47-53. PubMed ID: 31152973
[TBL] [Abstract][Full Text] [Related]
25. Clinical aspects of SDHx-related pheochromocytoma and paraganglioma.
Timmers HJ; Gimenez-Roqueplo AP; Mannelli M; Pacak K
Endocr Relat Cancer; 2009 Jun; 16(2):391-400. PubMed ID: 19190077
[TBL] [Abstract][Full Text] [Related]
26.
Kan Y; Zhang S; Wang W; Liu J; Yang J; Wang Z
Acta Radiol; 2018 Dec; 59(12):1466-1474. PubMed ID: 29566550
[TBL] [Abstract][Full Text] [Related]
27. Clinical value of somatostatin receptor imaging in patients with suspected head and neck paragangliomas.
Schmidt M; Fischer E; Dietlein M; Michel O; Weber K; Moka D; Stennert E; Schicha H
Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1571-80. PubMed ID: 12458390
[TBL] [Abstract][Full Text] [Related]
28. 68Ga-DOTANOC PET/CT for baseline evaluation of patients with head and neck paraganglioma.
Sharma P; Thakar A; Suman K C S; Dhull VS; Singh H; Naswa N; Reddy RM; Karunanithi S; Kumar R; Kumar R; Malhotra A; Bal C
J Nucl Med; 2013 Jun; 54(6):841-7. PubMed ID: 23520216
[TBL] [Abstract][Full Text] [Related]
29. Modern nuclear imaging for paragangliomas: beyond SPECT.
Taïeb D; Neumann H; Rubello D; Al-Nahhas A; Guillet B; Hindié E
J Nucl Med; 2012 Feb; 53(2):264-74. PubMed ID: 22302963
[TBL] [Abstract][Full Text] [Related]
30. Pheochromocytoma and paraganglioma: current functional and future molecular imaging.
Blanchet EM; Martucci V; Pacak K
Front Oncol; 2011; 1():58. PubMed ID: 22655253
[TBL] [Abstract][Full Text] [Related]
31. British Skull Base Society Clinical Consensus Document on Management of Head and Neck Paragangliomas.
Lloyd S; Obholzer R; Tysome J;
Otolaryngol Head Neck Surg; 2020 Sep; 163(3):400-409. PubMed ID: 32340547
[TBL] [Abstract][Full Text] [Related]
32. Preoperative 18F-FDG PET/CT in Pheochromocytomas and Paragangliomas Allows for Precision Surgery.
Nockel P; El Lakis M; Gaitanidis A; Merkel R; Patel D; Nilubol N; Prodanov T; Pacak K; Kebebew E
Ann Surg; 2019 Apr; 269(4):741-747. PubMed ID: 29334561
[TBL] [Abstract][Full Text] [Related]
33. Imaging and management of head and neck paragangliomas.
van den Berg R
Eur Radiol; 2005 Jul; 15(7):1310-8. PubMed ID: 15809825
[TBL] [Abstract][Full Text] [Related]
34. Head and Neck Paragangliomas-A Genetic Overview.
Majewska A; Budny B; Ziemnicka K; Ruchała M; Wierzbicka M
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081307
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance and peculiarities of succinate dehydrogenase B and hypoxia inducible factor 1α expression in parasympathetic versus sympathetic paragangliomas.
Bernardo-Castiñeira C; Sáenz-de-Santa-María I; Valdés N; Astudillo A; Balbín M; Pitiot AS; Jiménez-Fonseca P; Scola B; Tena I; Molina-Garrido MJ; Sevilla MA; Beristein E; Forga L; Villabona C; Oriola J; Halperin I; Suarez C; Chiara MD
Head Neck; 2019 Jan; 41(1):79-91. PubMed ID: 30549360
[TBL] [Abstract][Full Text] [Related]
36. Effects of octreotide therapy in progressive head and neck paragangliomas: case series.
van Hulsteijn LT; van Duinen N; Verbist BM; Jansen JC; van der Klaauw AA; Smit JW; Corssmit EP
Head Neck; 2013 Dec; 35(12):E391-6. PubMed ID: 23606330
[TBL] [Abstract][Full Text] [Related]
37. Quantitative biomarkers allow the diagnosis of head and neck paraganglioma on multiparametric MRI.
Arsovic E; Montava M; Fakhry N; Lavieille JP; Pacak K; Taïeb D; Varoquaux A
Eur J Radiol; 2021 Oct; 143():109911. PubMed ID: 34508941
[TBL] [Abstract][Full Text] [Related]
38. Necessity for long-term follow-up of patients with head and neck paraganglioma and mutation in the succinate dehydrogenase genes: an index case report and literature review.
Samji KB; Crown AL; Buxton-Thomas MS; Aylwin SJ; Schulte KM; Dizdarevic S
Endocr Pract; 2012; 18(5):e130-4. PubMed ID: 22982783
[TBL] [Abstract][Full Text] [Related]
39. (68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity.
Chang CA; Pattison DA; Tothill RW; Kong G; Akhurst TJ; Hicks RJ; Hofman MS
Cancer Imaging; 2016 Aug; 16(1):22. PubMed ID: 27535829
[TBL] [Abstract][Full Text] [Related]
40. Clinical impact of somatostatin receptor scintigraphy in the management of paragangliomas of the head and neck.
Duet M; Sauvaget E; Pételle B; Rizzo N; Guichard JP; Wassef M; Le Cloirec J; Herman P; Tran Ba Huy P
J Nucl Med; 2003 Nov; 44(11):1767-74. PubMed ID: 14602858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
